Full Course Description


Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians

Program Information

Outline

Antimicrobials

  • Drug classes
  • Pharmacokinetic Properties
    • Concentration-dependent killing
    • Time-dependent killing
    • Post-antibiotic effect
  • Common interactions with other drugs

Antibacterial Allergies - Sulfa and Penicillin

  • Define true allergy
  • Sulfonamide antibiotics vs non-antibiotics
  • Penicillin - Cephalosporin cross-sensitivity

Bacteria

  • Differentiation
  • Normal flora
  • Common pathogens

Antibacterial Resistance - Contributing Factors

  • Trends
  • Mechanisms of resistance
  • Contributing factors

Methicillin-Resistant Staphylococcus Aureus - Community versus Hospital Acquired

  • Differentiating between CA- and HA-MRSA
  • Current clinical practice guidelines
  • Pharmacologic management

Enterobacteriaceae Resistance

  • Extended Spectrum Beta-Lactamase (ESBL)
    • What are ESBLs
    • Pharmacologic management
  • Carbapenem-Resistant Enterobacteriaceae (CRE)
    • What are CREs
    • Pharmacologic management

Urinary Tract Infections

  • Bacterial Etiology, Signs and Symptoms and Diagnosis
  • Cystitis and pyelonephritis
  • Complicated and uncomplicated
  • UTIs in pregnancy
  • Treatment (IDSA Guideline Treatment Algorithm)
    • Acute
    • Recurrent and relapse

Clostridium Difficile Infection

  • Risk factors
  • Pharmacology management
  • Fecal Transplantation
  • Probiotics literature review

Community–Acquired Pneumonia

  • Bacterial etiology
  • Diagnosis
  • Typical vs. atypical
  • Treatment (IDSA/ATS Guidelines) and monitoring
    • Outpatient vs. inpatient
    • Empiric treatment

Healthcare–Associated Pneumonia

  • Bacterial etiology
  • Treatment (IDSA/ATS Guidelines)

Upper Respiratory Tract Infections

  • Sinusitis and pharyngitis
    • Etiology (Viral vs. Bacterial)
    • Treatment

Skin and Soft Tissue Infections

  • Cellulitis
  • Bacterial etiology
    • Strep. vs. Staph. vs. MRSA
    • Signs & symptoms
    • Treatment (IDSA Guidelines)

Influenza

  • Clinical features
  • Diagnosis
  • Pharmacology management

Immunizations (Adult)

  • Types of Vaccines
  • General recommendations
  • Contraindications & precautions

Objectives

  1. Develop antibiotic recommendations in response to microbiologic testing results.
  2. Describe clinical scenarios compelling for empiric coverage of resistant bacteria.
  3. Discriminate clinical scenarios requiring initiation of antibiotics.
  4. Choose appropriate risk factor–based empiric antibiotic regimens for acute infections.
  5. Recognize clinical scenarios necessitating avoidance of specific antibiotics based on side effect profiles.
  6. Identify clinical situations appropriate for newly approved antimicrobials.

Target Audience

  • Nurses
  • Advanced Practice Nurses
  • Clinical Nurse Specialists
  • Pharmacists
  • Nurse Practitioners
  • Physician Assistants

Copyright : 03/19/2019

Influenza Update: Nursing Strategies to Save Patient Lives

Program Information

Objectives

  1. Identify the three subtypes of Influenza
  2. Discuss how effective the Influenza vaccine in protection in reducing infection, hospitalization and death
  3. Explain symptoms of Influenza compared to common cold

Outline

Types of Influenza virus

  • A
  • B
  • C

Epidemiology of Influenza in USA and World

  • 12-56 thousand expire annually in USA
  • 5 Million expire annually in world
  • 200,000 hospitalized each year

Complication of Influenza

  • Pneumonia
  • ARDs
  • Seizures
  • Death

Symptoms of Influenza

  • Sudden onset
  • High fever
  • Muscle aches
  • Etc.

How composition of influenza vaccine determined

  • Southern hemisphere
  • Circulating types of influenza
  •  Surveillance

Treatments of Influenza

  • Oseltamivir
  • Zanamivir
  • Peremivir
  • Baloxavir (New)

Pandemics of Influenza

  • H1N1
  • H3N2
  • others

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Nurse Educators
  • Infection Preventionists

Copyright : 10/02/2019